ClinicalTrials.govpublic full text
A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD)
gastroesophageal reflux disease, symptoms of gastroesophageal reflux disease (gerd), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 968833
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.